(:AKRX)

Business Focus: N/A

May 03, 2023 11:30 am ET

Akorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company Shutdown

GURNEE, Ill., May 3, 2023 /PRNewswire/ -- Akorn Operating Company LLC has filed Chapter 7 bankruptcy on February 23, 2023. In connection with that filing, the company has ceased and shutdown all operations and terminated all its employees of all domestic US Sites. The Akorn Trustee is initiating a voluntary recall of various within-expiry human and animal products as a result of the closures and discontinuation of the Quality activities of these marketed products. (Refer to Attachment I and II*). The discontinuation of the Quality program means the company will not be able to support or guar

Apr 26, 2023 09:00 am ET

Akorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company Shutdown

GURNEE, Ill., April 26, 2023 /PRNewswire/ -- Akorn Operating Company LLC has filed Chapter 7 bankruptcy on February 23, 2023. In connection with that filing, the company has ceased and shutdown all operations and terminated all its employees of all domestic US Sites. The Akorn Trustee is initiating a voluntary recall of various within-expiry human and animal products as a result of the closures and discontinuation of the Quality activities of these marketed products. (Refer to Attachment I and II). The discontinuation of the Quality program means the company will not be able to support or gu

Oct 27, 2022 09:03 am ET

Akorn Introduces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg at ASRM

New generic featured in Booth 1102 at the American Society for Reproductive Medicine Conference (ASRM)

Aug 16, 2022 09:03 am ET

Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg

GURNEE, Ill., Aug. 16, 2022 /PRNewswire/ -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic version of Cetrorelix Acetate for Injection, 0.25 mg (Cetrorelix). This is the first approved AP-Rated bioequivalent version of Merck Serono's Cetrotide®.1

May 20, 2020 11:52 pm ET

Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term Success

LAKE FOREST, Ill., May 20, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company ("Akorn" or the "Company"), today announced that the Company and its U.S. subsidiaries filed for voluntary protection under Chapter 11 ("Chapter 11") of the U.S. Bankruptcy Code in United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") to execute an in‑court sale of its business while addressing litigation-related overhangs and best positioning the business for long-term success under new ownership. In connection with the filing, the Company has

May 11, 2020 05:14 pm ET

Akorn Provides First Quarter 2020 Results

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the first quarter of 2020. First Quarter 2020 Results and Recent Developments Net revenue was $205 million, up $39 million, 23% from...

May 01, 2020 10:45 am ET

Thinking about buying stock in Myomo, Microvision, Akorn Inc, Callon Petroleum, or Recon Technology?

NEW YORK, May 1, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MYO, MVIS, AKRX, CPE, and RCON.

Apr 27, 2020 06:17 pm ET

Enphase Energy and Paylocity Set to Join S&P MidCap 400; Core Laboratories and Meredith to Join S&P SmallCap 600

NEW YORK, April 27, 2020 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Friday, May 1:

Apr 01, 2020 06:20 am ET

Akorn Provides Update on Sale Process

LAKE FOREST, Ill., April 1, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it no longer has any bids in the Sale Process that are sufficient to pay all obligations under its term loan agreement. Accordingly, the Company now toggles to the alternative milestones that were detailed in the Second Amended Standstill Agreement and are summarized in the 8-K filed earlier today.

Feb 26, 2020 04:58 pm ET

Akorn Provides Fourth Quarter and Full Year 2019 Results

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the quarter and year ended December 31, 2019. Fourth Quarter 2019 Results and Recent Developments Net revenue was $162 million, an...

Dec 16, 2019 07:51 am ET

Akorn Announces Extension of Standstill Agreement

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that Akorn and certain of its lenders have reached an agreement that extends the standstill period to February 7, 2020. Doug Boothe, Akorn’s President and...

Nov 05, 2019 07:00 pm ET

Akorn to Present at the Credit Suisse Healthcare Conference

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that management will present at the Credit Suisse 28th Annual Healthcare Conference on Wednesday, November 13, 2019 at 10:55 a.m. Mountain Time, in Scottsdale,...

Oct 31, 2019 07:00 am ET

Akorn Provides Preliminary Third Quarter 2019 Results

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its preliminary financial results for the third quarter of 2019. Third Quarter 2019 and Recent Business Highlights Net revenue was $176 million, up $11...

Oct 14, 2019 04:25 pm ET

Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for betamethasone dipropionate lotion...

Oct 14, 2019 01:05 pm ET

Akorn to Report Third Quarter 2019 Financial Results and Host Conference Call

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it plans to issue a press release before market open on Thursday, October 31, 2019 outlining its third quarter 2019 financial results. In addition, the...

Aug 26, 2019 01:35 pm ET

Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for Azelastine Hydrochloride...

Aug 01, 2019 07:00 am ET

Akorn Provides Preliminary Second Quarter 2019 Results

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its preliminary financial results for the second quarter of 2019. Second Quarter 2019 and Recent Business Highlights Net revenue was $178 million,...

Jul 11, 2019 04:32 pm ET

Akorn to Report Second Quarter 2019 Financial Results and Host Conference Call

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release before market open on Thursday, August 1, 2019 outlining its second quarter 2019 financial results. In...

Jun 28, 2019 07:00 am ET

Akorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it has launched its first-to-market generic of Loteprednol Etabonate Ophthalmic Suspension, 0.5%. Douglas Boothe, Akorn’s President and Chief...

Jun 25, 2019 07:35 am ET

Akorn Receives FDA Warning Letter

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter from the U.S. Food and Drug Administration (FDA) related to the inspection of its Somerset, New Jersey manufacturing...

May 30, 2019 07:59 am ET

Akorn to Present at the Jefferies 2019 Global Healthcare Conference

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that management will present at the Jefferies 2019 Global Healthcare Conference on Friday, June 7, 2019 at 9:30 a.m. EDT in New York, NY. A live webcast...

May 20, 2019 04:05 pm ET

Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.1%

May 20, 2019 08:01 am ET

Akorn to Present at the RBC Capital Markets Healthcare Conference

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that management will present at the 2019 RBC Capital Markets Healthcare Conference on Wednesday, May 22, 2019 at 2:05 p.m. EDT in New York, NY. A live...

May 07, 2019 07:05 am ET

Akorn Provides Preliminary First Quarter 2019 Results and Full Year Guidance

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its preliminary financial results for the first quarter of 2019. First Quarter 2019 and Recent Business Highlights Net revenue was $166 million, up...

Apr 22, 2019 07:00 pm ET

Glancy Prongay & Murray LLP Files a Securities Class Action Notifying Investors of Expanded Class Period (AKRX)

Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District Court for the Northern District of Illinois, captioned Juan v. Akorn Inc. et al., (Case No. 19-cv-2720), on behalf of persons and entities that purchased or otherwise acquired Akorn, Inc.

Apr 22, 2019 03:00 pm ET

FINAL DEADLINE ALERT - AKRX, HIIQ & AMRN - Bronstein, Gewirtz & Grossman, LLC

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...

Apr 22, 2019 02:27 pm ET

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the April 22, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX) securities...

Apr 22, 2019 11:09 am ET

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akorn, Inc. (“Akorn” or “the Company”) (NASDAQ: AKRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...

Apr 19, 2019 05:36 pm ET

Block & Leviton LLP Reminds Shareholders of Important Deadlines: AKRX, SYNH, INGN, BPI

Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines listed below. If you have purchased or otherwise acquired any of the securities listed below,...

Apr 18, 2019 05:00 pm ET

Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Suspension, 0.5%

Apr 18, 2019 04:05 pm ET

Akorn Receives FDA Approval for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC)

Apr 18, 2019 01:47 pm ET

APRIL 22 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Akorn, Inc. (NASDAQ: AKRX) from August 1, 2018 through January 8, 2019, inclusive (the “Class Period”). The lawsuit seeks to...

Apr 18, 2019 11:51 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

Pomerantz LLP announces that a class action lawsuit has been filed against Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX) and certain of its officers and directors. The class action, filed in United States District Court, Northern District...

Apr 17, 2019 08:41 pm ET

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc.

Apr 15, 2019 05:31 pm ET

AKORN APRIL 22nd DEADLINE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important Deadline in Securities Class Action Lawsuit Filed by the Firm – AKRX

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akorn, Inc. from August 1, 2018 through January 8, 2019, inclusive (the “Class Period”) of the important April 22, 2019 lead plaintiff deadline in the class...

Apr 15, 2019 01:56 pm ET

Akorn to Report First Quarter 2019 Financial Results and Host Conference Call

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release before market open on Tuesday, May 7, 2019 outlining its first quarter 2019 financial results. In addition, the...

Apr 15, 2019 10:20 am ET

Block & Leviton LLP Reminds Shareholders of Important Deadlines: TAP, AKRX, SYNH, CTL

Apr 12, 2019 03:00 pm ET

AKRX, HIIQ & AMRN - Class Action Reminder Bronstein, Gewirtz & Grossman, LLC

Apr 10, 2019 10:21 pm ET

AKRX ALERT: Zhang Investor Law Reminds Investors of April 22 Deadline in Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Akorn, Inc. (NASDAQ: AKRX) from August 1, 2018 through January 8, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover...

Apr 09, 2019 08:31 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX

NEW YORK, April 9, 2019 /CNW/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) and certain of its officers and directors. The class action, filed in United States District Court, Northern District of Illinois, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired publicly traded securities of Akorn from August 1, 2018 through January 8, 2019, inclusive (the "Class Period"), seeking to recover compensable damages caused

Apr 09, 2019 08:31 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX

NEW YORK, April 9, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) and certain of its officers and directors. The class action, filed in United States District Court, Northern District of Illinois, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired publicly traded securities of Akorn from August 1, 2018 through January 8, 2019, inclusive (the "Class Period"), seeking to recover compensable damages

Apr 08, 2019 05:27 pm ET

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In AKRX, UMC, CAG or CNDT To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, encourages investors in the following companies to contact the firm: Company: Akorn, Inc. (NASDAQ:AKRX)Lead Plaintiff Deadline: April 22, 2019Class Period: August 1, 2018 and January...

Apr 07, 2019 09:00 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

Apr 05, 2019 03:00 pm ET

Class Action Reminder – AKRX, HIIQ & AMRN Bronstein, Gewirtz & Grossman, LLC

Apr 02, 2019 05:34 pm ET

AKORN CLASS ACTION NOTICE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important April 22nd Deadline in Securities Class Action Lawsuit Filed by the Firm – AKRX

Apr 02, 2019 05:25 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. ("Akorn" or the "Company")(NASDAQ:AKRX) of the April 22, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Apr 02, 2019 03:24 pm ET

Block & Leviton LLP Reminds Shareholders of Important Deadlines: TAP, AKRX, SYNH, CTL

Mar 29, 2019 04:33 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. ("Akorn" or the "Company")(NASDAQ: AKRX) of the April 22, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Mar 29, 2019 01:54 pm ET

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc.

Mar 28, 2019 08:27 pm ET

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc. (AKRX)

Law Offices of Howard G. Smith reminds investors of the upcoming April 22, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX) securities between August 1, 2018 and January 8, 2019, inclusive

Mar 28, 2019 04:12 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. ("Akorn" or the "Company")(NASDAQ: AKRX) of the April 22, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has...

Mar 28, 2019 03:00 pm ET

Class Action Reminder – AKRX, HIIQ & AMRN Bronstein, Gewirtz & Grossman, LLC

Mar 28, 2019 02:27 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

Mar 27, 2019 05:15 pm ET

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Akorn, Inc. Investors

Glancy Prongay & Murray LLP (“GPM”), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that acquired Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:

Mar 27, 2019 04:39 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) of the April 22, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has...

Mar 26, 2019 06:30 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akorn, Inc. Investors (AKRX)

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX) securities between August 1, 2018 and January 8, 2019, inclusive (the “Class Period”). Akorn investors have until April 22, 2019 to

Mar 26, 2019 05:04 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. ("Akorn" or the "Company")(NASDAQ: AKRX) of the April 22, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has...

Mar 26, 2019 10:46 am ET

AKRX DEADLINE ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

Mar 25, 2019 02:13 pm ET

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akorn, Inc. Investors

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:

Mar 25, 2019 11:41 am ET

Block & Leviton LLP Reminds Shareholders of Important Deadlines: TAP, AKRX, SYNH, CTL

Mar 22, 2019 05:10 pm ET

AKRX INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Akorn, Inc. Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Akorn, Inc. investors (“Akorn” or the “Company”) (NASDAQ: AKRX) concerning the Company and its officers’ possible violations of federal securities laws.

Mar 21, 2019 06:29 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

Mar 21, 2019 08:14 am ET

Block & Leviton LLP Reminds Shareholders of Important Deadlines: MU, AKRX, SYNH, CTL

Mar 21, 2019 07:00 am ET

Akorn Names Erislandy (Dandy) Dorado-Boladeres as Executive Vice President of Global Quality

Akorn, Inc. (NASDAQ: AKRX), today announced that Dandy Dorado-Boladeres has been named as Executive Vice President of Global Quality, effective March 25, 2019. Mr. Dorado brings decades of pharmaceutical industry experience and expertise with a...

Mar 20, 2019 09:09 pm ET

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

Mar 20, 2019 04:00 pm ET

Class Action AKRX, AMRN & CAG Bronstein, Gewirtz & Grossman, LLC Update

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...

Mar 20, 2019 02:50 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. ("Akorn" or the "Company") (NASDAQ:AKRX) of the April 22, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Mar 19, 2019 08:30 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

NEW YORK, March 19, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. ("Akorn" or the "Company")(NASDAQ: AKRX) of the April 22, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Mar 18, 2019 10:38 am ET

Block & Leviton LLP Reminds Shareholders of Important Deadlines: MU, AKRX, SYNH, CTL

Mar 15, 2019 02:00 pm ET

Akorn, Inc. (AKRX) Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against and Lead Deadline: April 22, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Akorn Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX) and certain of its officers, on behalf of shareholders who...

Mar 14, 2019 09:18 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

Mar 14, 2019 10:51 am ET

Block & Leviton LLP Reminds Shareholders of Important Deadlines: MU, AKRX, SYNH, CTL

Mar 12, 2019 03:33 pm ET

AKRX DEADLINE ALERT: Zhang Investor Law Reminds of April 22 Deadline in Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Akorn, Inc. (NASDAQ: AKRX) from August 1, 2018 through January 8, 2019, inclusive. The lawsuit seeks to recover damages for Akorn...

Mar 11, 2019 06:53 pm ET

AKRX INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Akorn, Inc. Investors

Mar 08, 2019 04:17 pm ET

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akorn, Inc. Investors

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX) investors concerning the Company and its officers’ possible violations of federal securities laws. To obtain...

Mar 07, 2019 06:59 pm ET

Pomerantz Law Firm Announces the Filing of a Class Action against Akorn, Inc. and Certain Officers – AKRX

Mar 07, 2019 04:10 pm ET

AKORN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern Distr

Wolf Haldenstein Adler Freeman & Herz LLP announces the filing of a federal securities class action lawsuit in the United States District Court for the Northern District of Illinois on behalf of investors who bought shares of Akorn, Inc. (NASDAQ:...

Mar 07, 2019 11:28 am ET

INVESTOR ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Akorn, Inc. - AKRX

NEW YORK, March 7, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Akorn, Inc. (NASDAQ: AKRX) from August 1, 2018 through January 8, 2019, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Akorn investors under the federal securities laws.

Mar 05, 2019 10:31 am ET

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Mar 04, 2019 10:53 am ET

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akorn, Inc. (“Akorn” or “the Company”) (NASDAQ:

Mar 01, 2019 06:02 pm ET

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akorn, Inc. (“Akorn” or “the Company”) (NASDAQ:

Mar 01, 2019 05:17 pm ET

Akorn Comments on Favorable Court Order

Akorn, Inc. (Nasdaq: AKRX) announced today that the Delaware Court of Chancery has denied a request by Fresenius Kabi AG to bring a fraud claim against Akorn. On February 20, Fresenius filed a proposed amended counterclaim seeking to add a new...

Mar 01, 2019 03:42 pm ET

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

Mar 01, 2019 11:29 am ET

Pomerantz Law Firm Announces the Filing of a Class Action against Akorn, Inc. and Certain Officers – AKRX

Feb 28, 2019 01:09 pm ET

Akorn, Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX) and certain of its officers and directors violated federal...

Feb 28, 2019 07:00 am ET

Akorn Provides Fourth Quarter and Full Year 2018 Results

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its financial results for the year ended 2018. Fourth Quarter 2018 and Recent Business Highlights Net revenue was $153 million, a decline of $33...

Feb 27, 2019 04:05 pm ET

AKORN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of I

Feb 25, 2019 05:42 pm ET

INVESTOR ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Akorn, Inc. (NASDAQ: AKRX) from August 1, 2018 through January 8, 2019, inclusive (the “Class Period”)....

Feb 22, 2019 01:03 pm ET

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Akorn, Inc.

Federman & Sherwood announces that on February 21, 2019, a class action lawsuit was filed in the United States District Court for the Northern District of Illinois against Akorn, Inc. (NASDAQ: AKRX). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is August 1, 2018 t

Feb 21, 2019 03:41 pm ET

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Akorn, Inc. (NASDAQ:AKRX) from August 1, 2018 through January 8, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Akorn investors under the federal securities laws.

Feb 20, 2019 05:25 pm ET

Akorn Comments on Fresenius’ Proposed Amended Claims

Akorn, Inc. (Nasdaq: AKRX) today announced that it strongly contests Fresenius’ proposed amended claims filed earlier today. Akorn believes these claims are meritless and overreaching. Akorn denies the allegations and will vigorously defend itself...

Feb 20, 2019 09:38 am ET

AKRX INVESTOR LOSSES ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Akorn, Inc.; Akorn Investors are Encouraged to Contact the Firm – AKRX

Rosen Law Firm, a global investor rights law firm, announces it is continuing to investigate potential securities claims on behalf of shareholders of Akorn, Inc. (NASDAQ: AKRX) resulting from allegations that Akorn may have issued materially...

Feb 15, 2019 10:09 am ET

EQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Akorn, Inc. – AKRX

Feb 11, 2019 04:38 pm ET

Akorn to Report Fourth Quarter and Full Year 2018 Results

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Thursday, February 28, 2019 outlining the fourth quarter and full year 2018 results. In addition, the Company...

Feb 01, 2019 01:02 pm ET

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akorn, Inc. (“Akorn” or “the Company”) (NASDAQ: AKRX) for violations of §§10(b) and 20(a) of the Securities...

Jan 31, 2019 02:16 pm ET

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akorn, Inc. (“Akorn” or “the Company”) (NASDAQ:

Jan 31, 2019 12:27 pm ET

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akorn Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX). Such investors are encouraged to obtain additional information and assist...

Jan 30, 2019 02:43 pm ET

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akorn, Inc. (“Akorn” or “the Company”) (NASDAQ:

Jan 30, 2019 11:19 am ET

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Akorn, Inc. – AKRX

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Akorn, Inc. (NASDAQ: AKRX) resulting from allegations that Akorn may have issued materially misleading business information to the investing public.

Jan 30, 2019 10:12 am ET

Akorn, Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

Jan 28, 2019 04:30 pm ET

Akorn Announces New Executive and Board Appointments

Akorn, Inc. (Nasdaq: AKRX), today announced that it has appointed a new executive team member and two new board members. Christopher C. Young joins Akorn as Executive Vice President, Global Operations reporting to Douglas Boothe, President & Chief...

Jan 09, 2019 06:07 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akorn, Inc. - AKRX

NEW YORK, Jan. 9, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

Jan 09, 2019 07:55 am ET

Akorn Receives FDA Warning Letter

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter, dated January 4, from the U.S. Food and Drug Administration (FDA) related to an inspection of its Decatur, Illinois...

Jan 08, 2019 06:30 pm ET

Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akorn, Inc. (NASDAQ: AKRX), today announced that Akorn granted an inducement equity award in accordance with Nasdaq Listing Rule 5635(c)(4) pursuant to an employment arrangement with Akorn’s newly appointed President and Chief Executive Officer...

Dec 21, 2018 02:00 pm ET

Robbins Arroyo LLP: Shareholder Lawsuit Filed Against Officers and Directors of Akorn, Inc. (AKRX)

Shareholder rights law firm Robbins Arroyo LLP reminds investors that a shareholder of Akorn, Inc. (NASDAQ: AKRX) has filed a lawsuit against the company's officers and directors for breaches of fiduciary duty from 2014 through the present. Akorn is a specialty generic pharmaceutical company.

Dec 20, 2018 05:05 pm ET

Akorn Names Douglas S. Boothe as President and CEO

Akorn, Inc. (NASDAQ: AKRX), today announced that Douglas S. Boothe has been named president and chief executive officer effective January 1, 2019, bringing deep pharmaceuticals expertise and a proven track record as Akorn looks forward to its next...

Dec 10, 2018 03:18 pm ET

Robbins Arroyo LLP: Shareholder Lawsuit Filed Against Officers and Directors of Akorn, Inc. (AKRX)

Shareholder rights law firm Robbins Arroyo LLP reminds investors that a shareholder of Akorn, Inc. (NasdaqGS: AKRX) has filed a shareholder lawsuit against the company's officers and directors for breaches of fiduciary duty from 2014 through the present. Akorn is a specialty generic pharmaceutical company.

Dec 07, 2018 05:04 pm ET

Supreme Court of the State of Delaware Rules Against Akorn, New CEO Search Underway

Akorn, Inc. (NASDAQ: AKRX) today said it will move forward and rebuild shareholder value as an independent company following the disappointing decision from the Supreme Court of the State of Delaware upholding the lower court’s decision to allow...

Nov 26, 2018 05:29 pm ET

Akorn Receives Product Approval

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration for diclofenac sodium topical gel, 1%. The...

Nov 12, 2018 09:08 am ET

Investor Alert - Akorn, Inc. (AKRX) – Kehoe Law Firm, P.C. Investigating Potential Claims Against Certain Officers and Directors of Akorn, Inc.

Akorn’s common stock shares (NasdaqGS: AKRX) fell more than 58%, closing at $5.36 on October 1, 2018, on news of a recent Delaware Court ruling that determined that Fresenius SE could walk away from its $4.3 billion deal to buy pharmaceutical...

Nov 07, 2018 04:48 pm ET

Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Akorn, Inc. (AKRX) and Encourages AKRX Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Akorn, Inc. (NASDAQ: AKRX). In a recent ruling, a Delaware Court determined that Fresenius SE could walk away from its $4.3 billion deal to buy...

Nov 06, 2018 05:10 pm ET

Akorn Provides Third Quarter 2018 Results

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its financial results for the third quarter of 2018. Business Highlights Revenues declined predominantly due to the effect of competition on key...

Oct 29, 2018 07:05 am ET

Akorn Receives Product Approval

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that, on October 26, 2018, it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration for Clobetasol...

Oct 23, 2018 05:56 pm ET

Resideo Technologies Set to Join S&P MidCap 400; Akorn to Join S&P SmallCap 600

NEW YORK, Oct. 23, 2018 /PRNewswire/ -- Resideo Technologies Inc. (NYSE: REZI) will replace Akorn Inc. (NASD: AKRX) in the S&P MidCap 400, and Akorn will replace Big 5 Sporting Goods Corp. (NASD: BGFV) in the S&P SmallCap 600 effective prior to the open of trading on Tuesday, October 30. S&P 100 & 500 constituent Honeywell International Inc. (NYSE: HON) is spinning-off Resideo Technologies to shareholders in a deal expected to be completed on October 29. Akorn and Big 5 Sporting Goods are ranked near the bottom of their respective indices and are no longer representative of t

Oct 18, 2018 01:47 pm ET

Akorn Appeals Fresenius Kabi Ruling

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that the company filed a notice of appeal to the Supreme Court of the State of Delaware from the recent decision of the Delaware Court of Chancery...

Oct 17, 2018 12:15 pm ET

RM LAW Announces Investigation of Akorn, Inc.

BERWYN, Pa., Oct. 17, 2018 /PRNewswire/ -- RM LAW, P.C. has commenced an investigation into potential securities law violations by certain officers of Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX).

Oct 11, 2018 05:19 pm ET

Robbins Arroyo LLP Is Investigating the Officers and Directors of Akorn, Inc. (AKRX) on Behalf of Shareholders

Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Akorn, Inc. (NasdaqGS: AKRX) breached their fiduciary duties to shareholders. In a landmark ruling last week, a Delaware Court determined that Fresenius SE could walk away from its $4.3 billion deal

Oct 10, 2018 07:05 am ET

Akorn Receives Product Approval

Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it has received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for Bimatoprost Ophthalmic...

Oct 01, 2018 09:25 am ET

Akorn Comments on Delaware Chancery Court Ruling

Akorn, Inc. (NASDAQ:AKRX), today issued the following statement in response to the ruling by the Delaware Chancery Court on the complaint filed by Akorn against Fresenius Kabi AG:

Aug 01, 2018 08:00 am ET

Factors of Influence in 2018, Key Indicators and Opportunity within Five Prime Therapeutics, Akorn, The Blackstone Group, Avaya, Tractor Supply, and CymaBay Therapeutics — New Research Emphasizes Econ

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Five Prime Therapeutics, Inc. (NASDAQ:FPRX), Akorn, Inc. (NASDAQ:AKRX),...

Jun 04, 2018 09:10 am ET

Lawsuit for Investors in shares of Akorn, Inc. (NASDAQ: AKRX) announced by Shareholders Foundation

The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Akorn, Inc. (NASDAQ: AKRX) shares. Investors who purchased shares of Akorn, Inc. (NASDAQ:AKRX) in March 2017 or earlier and continue to hold NASDAQ:...

May 29, 2018 03:31 pm ET

Moore Kuehn, PLLC Announces an Investigation Involving Possible Breaches of Fiduciary Duties by Officers and Directors of Akorn, Inc.

NEW YORK, May 29, 2018 /PRNewswire/ -- Moore Kuehn, PLLC is investigating potential claims for breach of fiduciary duty involving the directors and officers of Akorn, Inc. (NASDAQ: AKRX). On February 26, 2018 Fresenius SE & Co. KGaA ("Fresenius") announced it is conducting an investigation into alleged breaches of FDA data integrity requirements at Akorn Inc. Shareholders may be entitled to certain corporate governance reforms.

May 02, 2018 11:48 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

Pomerantz LLP announces that a class action lawsuit has been filed against Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX) and certain of its officers. The class action, filed in United States District Court, for the District of Illinois, Eastern Division, is on behalf of a class consisting of investors who purchased or otherwise acquired Akorn’s securities between March 1, 2017 through February 26, 2018, both dates inclusive (the “Class Period”), seeking to recover damages caused by defendants’ violations of the federal securities laws

May 02, 2018 10:00 am ET

FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akorn, Inc. (Nasd

STEVENSON, Md., May 02, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of...

May 01, 2018 03:54 pm ET

Rosen Law Firm Reminds Akorn, Inc. Investors of Important May 7 Deadline in Class Action – AKRX

NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akorn, Inc. (NASDAQ:AKRX) from March 1, 2017 through February 26, 2018, both dates inclusive (“Class...

Apr 30, 2018 10:00 am ET

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) & Lead Plaintiff Deadline: May 7, 2018

NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX) and certain of its officers, on behalf of...

Apr 24, 2018 01:46 pm ET

Lifshitz & Miller LLP Announces Investigation of Acadia Healthcare Company, Inc., Akorn, Inc., Blackhawk Network Holdings, Inc., Facebook, Inc., IZEA Inc., MuleSoft, Inc., Solid Biosciences Inc., and

NEW YORK, April 24, 2018 /PRNewswire/ --

Apr 24, 2018 10:28 am ET

AKORN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern Dist

Impending Lead Plaintiff Deadline is May 7, 2018

Apr 23, 2018 05:29 pm ET

AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Akorn, Inc.To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX) of the May 7, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Apr 23, 2018 02:23 pm ET

The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Akorn, Inc. Shareholders and a Lead Plaintiff Deadline of May 7, 2018 (AKRX)

NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Akorn, Inc. (NASDAQ:AKRX) who purchased shares between March 1, 2017 and February...

Apr 23, 2018 10:00 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

Apr 23, 2018 09:00 am ET

Should you buy or sell Akorn Inc., Google, Halliburton, Hasbro and Verizon Communications?

CHICAGO, April 23, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AKRX, GOOGL, HAL, HAS, and VZ.

Apr 23, 2018 08:43 am ET

Akorn Asks Delaware Court to Require Fresenius Kabi to Fulfill Its Obligations under Merger Agreement

Akorn, Inc. (NASDAQ:AKRX), today filed a complaint in Delaware Chancery Court asking that Fresenius Kabi AG be required to fulfill its obligations under the definitive merger agreement, and issued the following statement:

Apr 22, 2018 04:16 pm ET

Akorn Issues Statement

Akorn, Inc. (NASDAQ:AKRX), today issued a statement in response to Fresenius Kabi’s announcement that it is seeking to terminate the definitive merger agreement announced on April 24, 2017.

Apr 21, 2018 08:30 am ET

AKRX INVESTOR ALERT: Rosen Law Firm Reminds Akorn, Inc. Investors of Important May 7 Deadline in Class Action – AKRX

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akorn, Inc. (NASDAQ:AKRX) from March 1, 2017 through February 26, 2018, both dates inclusive (“Class Period”) of the important May 7, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Akorn investors under the federal securities laws.

Apr 20, 2018 08:30 am ET

Analysis: Positioning to Benefit within Team, Fortinet, Rockwell Collins, Franklin Street Properties, Akorn, and Targa Resources — Research Highlights Growth, Revenue, and Consolidated Results

NEW YORK, April 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Team, Inc. (NYSE:TISI), Fortinet, Inc. (NASDAQ:FTNT),...

Apr 19, 2018 11:31 am ET

AKRX EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Akorn, Inc. and a Lead Plaintiff Deadline of May 7, 2018

NEW YORK, April 19, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Illinois on behalf of investors...

Apr 18, 2018 08:00 pm ET

Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Akorn, Inc. – AKRX

NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- Safirstein Metcalf LLP announces that a class action has been filed in the United States District Court, for the District of Illinois, Eastern Division, on behalf of a class consisting...

Apr 18, 2018 04:07 pm ET

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Akorn, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 7, 2018 – AKRX

NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

Apr 12, 2018 06:00 am ET

DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Akorn, Inc. to Contact the Fir

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Illinois on behalf of purchasers of Akorn, Inc. (Nasdaq: AKRX) (“Akorn” or the “Company”) securities during the period between March 1, 2017 through February 26, 2018, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until May 7, 2018 to seek appointment as lead plaintiff.

Apr 11, 2018 07:50 pm ET

AKRX INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Akorn, Inc. Investors

Law Offices of Howard G. Smith continues its investigation on behalf of Akorn, Inc. investors (“Akorn ” or the “Company”) (NASDAQ: AKRX) concerning the Company and its officers’ possible violations of federal securities laws.

Apr 11, 2018 06:45 pm ET

AKORN ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akorn, Inc. - AKRX

NEW YORK, April 11, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Akorn, Inc. (NASDAQ: AKRX) from March 1, 2017 through February 26, 2018, both dates inclusive ("Class Period"). The lawsuit seeks to recover damages for Akorn investors under the federal securities laws.

Apr 11, 2018 05:39 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX

NEW YORK, April 11, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) and certain of its officers. The class action, filed in United States District Court, for the District of Illinois, Eastern Division, is on behalf of a class consisting of investors who purchased or otherwise acquired Akorn's securities between March 1, 2017 through February 26, 2018, both dates inclusive (the "Class Period"), seeking to recover damages caused by defendants' violations of the federal securities laws and to

Apr 10, 2018 06:14 pm ET

The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Akorn, Inc. Shareholders and a Lead Plaintiff Deadline of May 7, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Akorn, Inc. (NASDAQ: AKRX) who purchased shares between March 1, 2017 and February 26, 2018. The action, which was filed in the United States District Court for the District of Illinois, alleges that the Company violated federal securities laws.

Apr 09, 2018 02:45 pm ET

AKRX EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Akorn, Inc. and a Lead Plaintiff Deadline of May 7, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Illinois on behalf of investors who purchased Akorn, Inc. ("Akorn") (NASDAQ: AKRX) securities between March 1, 2017 and February 26, 2018.

Apr 09, 2018 01:46 pm ET

AKRX INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Class Action against Akorn, Inc.

The law firm Lieff Cabraser Heimann & Bernstein, LLP remind investors of upcoming deadline to move for appointment as lead plaintiff in the class action litigation that has been filed on behalf of investors who

Apr 04, 2018 03:00 pm ET

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Akorn, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 7, 2018

The following statement is being issued by Levi & Korsinsky, LLP:

Apr 03, 2018 04:30 pm ET

Hagens Berman Alerts Investors in Akorn, Inc. to the May 7, 2018 Lead Plaintiff Deadline in the Pending Securities Class Action

SAN FRANCISCO, April 03, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Akorn, Inc. (NASDAQ:AKRX) to the May 7, 2018 Lead Plaintiff deadline in the securities class action pending in the United States District...

Apr 03, 2018 04:29 pm ET

The Klein Law Firm Announces Commencement of a Class Action Filed on Behalf of Akorn, Inc. Shareholders and a Lead Plaintiff Deadline of May 7, 2018 (AKRX)

NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Akorn, Inc. (NASDAQ:AKRX) who purchased shares between March 1, 2017 and February...

Apr 03, 2018 02:01 pm ET

AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Akorn, Inc. To Contact The Firm

NEW YORK, April 3, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) of the May 7, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Apr 02, 2018 01:30 pm ET

The Klein Law Firm Announces a Class Action Filed on Behalf of Akorn, Inc. Shareholders and a Lead Plaintiff Deadline of May 7, 2018 (AKRX)

Apr 02, 2018 06:00 am ET

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Akorn, Inc. (Nasdaq: AKRX) To Contact Brower Piven Before The Lead Plaintiff Deadline In C

STEVENSON, Md., April 02, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of...

Mar 31, 2018 08:30 am ET

EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

NEW YORK, March 31, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Akorn, Inc. (NASDAQ:AKRX) from March...

Mar 28, 2018 05:48 pm ET

AKRX INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Akorn, Inc. and a Lead Plaintiff Deadline of May 7, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Illinois on behalf of investors who purchased Akorn, Inc. ("Akorn") (NASDAQ:AKRX) securities between March 1, 2017 and February 26, 2018.

Mar 28, 2018 05:26 pm ET

AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Akorn, Inc.To Contact The Firm

NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX) of the May 7, 2018 deadline to seek the role...

Mar 27, 2018 04:13 pm ET

AKRX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Akorn, Inc. and a Lead Plaintiff Deadline of May 7, 2018

NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Illinois on behalf of investors...

Mar 27, 2018 12:35 pm ET

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: May 7, 2018

NEW YORK, March 27, 2018 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) and certain of its officers, on behalf of shareholders who purchased Akorn securities during the period between March 1, 2017 through February 26, 2018, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: http://www.bgandg.com/akrx.

Mar 26, 2018 03:17 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX) and certain of its officers. The class action, filed in United...

Mar 26, 2018 03:08 pm ET

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Akorn, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 7, 2018

The following statement is being issued by Levi & Korsinsky, LLP:

Mar 23, 2018 07:18 pm ET

Robbins Arroyo LLP: Akorn, Inc. (AKRX) Misled Shareholders According to a Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Akorn, Inc. (NasdaqGS: AKRX) have filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between March 1, 2017 and February 26, 2018. Akorn, a specialty generic ph

Mar 23, 2018 03:36 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Akorn, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 7, 2018 – AKRX

NEW YORK, March 23, 2018 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

Mar 23, 2018 01:37 pm ET

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Akorn, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Law

Mar 21, 2018 01:50 pm ET

The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Akorn, Inc. (AKRX)

The Klein Law Firm announces the commencement of an investigation of Akorn, Inc. (NASDAQ: AKRX) concerning possible violations of federal securities laws.

Mar 16, 2018 05:00 pm ET

The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Akorn, Inc.

The Klein Law Firm announces the commencement of an investigation of Akorn, Inc. (NASDAQ:AKRX) concerning possible violations of federal securities laws.

Mar 16, 2018 02:52 pm ET

AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing in Akorn, Inc. to Contact the Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX).

Mar 15, 2018 03:30 pm ET

AKRX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Akorn, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX) violated federal securities laws.

Mar 14, 2018 02:23 pm ET

AKRX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Akorn, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX) violated federal securities laws.

Mar 13, 2018 09:45 pm ET

AKRX LOSS NOTICE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important Deadline in Class Action

Mar 13, 2018 04:15 pm ET

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akorn, Inc. (Nasdaq: AKRX) To Contact Brower Pi

STEVENSON, Md., March 13, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of...

Mar 12, 2018 01:08 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Akorn, Inc.

Levi & Korsinsky announces it has commenced an investigation of Akorn, Inc. (NASDAQ:AKRX) concerning possible violations of federal securities laws.

Mar 12, 2018 07:30 am ET

AKRX INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Akorn, Inc. Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Akorn, Inc. investors (“Akorn ” or the “Company”) (NASDAQ: AKRX) concerning the Company and its officers’ possible violations of federal securities laws.

Mar 09, 2018 08:00 pm ET

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Akorn, Inc. (AKRX)

NEW YORK, March 09, 2018 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX) in the United States District Court for the Northern...

Mar 09, 2018 02:08 pm ET

AKORN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern Dist

Lead Plaintiff Deadline is May 7, 2018

Mar 09, 2018 01:11 pm ET

Pomerantz Law Firm Announces the Filing of a Class Action against Akorn, Inc. and Certain Officers – AKRX

NEW YORK, March 09, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX) and certain of its officers. The class action, filed in United...

Mar 09, 2018 08:59 am ET

Block & Leviton LLP Announces The Filing Of A Class Action Against Akorn, Inc. (AKRX)

BOSTON, March 9, 2018 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, announces that a class action has been filed against Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) and certain of its officers for violations of the federal securities laws.

Mar 08, 2018 06:08 pm ET

AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing in Akorn, Inc. to Contact the Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX).

Mar 08, 2018 04:49 pm ET

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Akorn, Inc. (NASDAQ: AKRX) from March 1, 2017 through February 26, 2018, both dates inclusive (“Class Period”). The lawsuit seeks to recover damages for Akorn investors under the federal securities laws.

Mar 01, 2018 02:59 pm ET

AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Akorn, Inc. To Contact The Firm

NEW YORK, March 1, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX).

Feb 27, 2018 01:17 pm ET

Investor Alert: Kaplan Fox Announces Investigation Of Akorn, Inc.

NEW YORK, Feb. 27, 2018 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX), a specialty generic pharmaceutical company, concerning potential securities law violations. Investors who purchased Akorn securities may be affected.

Feb 27, 2018 12:27 pm ET

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX)

NEW YORK, Feb. 27, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/akrx.

Feb 27, 2018 12:21 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Akorn, Inc.

Levi & Korsinsky announces it has commenced an investigation of Akorn, Inc. (NASDAQ: AKRX) concerning possible violations of federal securities laws.

Feb 27, 2018 12:16 pm ET

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Akorn, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of purchasers of Akorn, Inc. (NASDAQ:AKRX) resulting from allegations that Akorn may have issued materially misleading business information to the investing public.

Feb 26, 2018 07:47 pm ET

Akorn Issues Statement on Investigation

LAKE FOREST, Ill., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today issued the following statement:

Feb 26, 2018 05:13 pm ET

Block & Leviton LLP Investigates Akorn, Inc. (AKRX) Following Investigation By Acquirer, Fresenius

BOSTON, Feb. 26, 2018 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) and certain of its officers and directors violated federal securities laws and encourage significant investors to contact the firm.

Feb 15, 2018 08:00 am ET

Factors of Influence in 2018, Key Indicators and Opportunity within Akorn, Autodesk, NextEra Energy Partners, LP, Hertz Global, Cinedigm, and Nektar Therapeutics — New Research Emphasizes Economic Gro

NEW YORK, Feb. 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Akorn, Inc. (NASDAQ:AKRX), Autodesk, Inc. (NASDAQ:ADSK),...

Feb 09, 2018 07:03 am ET

AKRX Investor Alert: Kyros Law is Filing Compensation Claims on Behalf of Akorn Pharmaceuticals (NASDAQ: AKRX) Investors

BOSTON, Feb. 9, 2018 /PRNewswire/ -- Kyros Law Offices is alerting investors of Akorn Pharmaceuticals (NASDAQ: AKRX) that it is filing legal claims on behalf of investors against the company for possible securities fraud violations..

Jan 26, 2018 01:09 pm ET

Pomerantz LLP and Glancy Prongay & Murray LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Akorn, Inc. - AKRX

Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Akorn, Inc. (NASDAQ: AKRX):

Jan 18, 2018 07:00 am ET

Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a propo

ROCKFORD, Ill., Jan. 18, 2018 /PRNewswire/ --

Jan 11, 2018 01:24 pm ET

Pomerantz LLP and Glancy Prongay & Murray LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Akorn, Inc. - AKRX

NEW YORK, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a...

Jan 04, 2018 07:00 am ET

Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a propo

ROCKFORD, Ill., Jan. 4, 2018 /PRNewswire/ --

Dec 28, 2017 05:40 pm ET

Pomerantz LLP and Glancy Prongay & Murray LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Akorn, Inc. - AKRX

Dec 01, 2017 08:00 am ET

Analysis: Positioning to Benefit within Hertz Global, Cinedigm, Nektar Therapeutics, Akorn, Autodesk, and NextEra Energy Partners, LP — Research Highlights Growth, Revenue, and Consolidated Results

NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hertz Global Holdings, Inc (NYSE:HTZ), Cinedigm...

Jul 19, 2017 04:30 pm ET

Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi

LAKE FOREST, Ill., July 19, 2017 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ:AKRX), a leading specialty generic pharmaceutical company, announced that its shareholders, at a special meeting held earlier today, have overwhelmingly voted to approve the previously announced merger agreement providing for the acquisition of Akorn by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA (FWB:FRE)....

Jul 07, 2017 10:01 pm ET

Johnson & Weaver, Announces Investigations of Omega Protein Corporation, Monogram Residential Trust, Inc. and Akorn, Inc.; Investors Encouraged to Contact Firm

SAN DIEGO, July 7, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential claims against Omega Protein Corporation, Monogram Residential Trust, Inc., and Akorn, Inc. as detailed below:

Jul 06, 2017 11:10 am ET

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: August 21, 2017

NEW YORK, July 6, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed on behalf of common stock shareholders of Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) in connection with the proposed sale of the Company to German based Fresenius Kabi AG ("Parent") through Parent's wholly-owned subsidiary, Quercus Acquisition, Inc. ("Merger Sub," and together with Parent, "Fresenius"), announced on April 24, 2017 (the "Complaint"). Such investors are encouraged to join this case by visiting the firm's

Jun 29, 2017 11:10 am ET

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX)

NEW YORK, June 29, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims of whether the board members of Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) breached their fiduciary duties in connection with the proposed sale of the Company to German based Fresenius Kabi. Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/akrx.

Jun 02, 2017 06:56 pm ET

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Akorn, Inc. (AKRX)

NEW YORK, June 02, 2017 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ:AKRX) in the United States District Court for the Middle District of Louisiana for violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”) in connection with the merger between Akorn and Fresenius Kabi AG (“Parent”) through Parent’s wholly-owned subsidiary, Quercus Acquisition, Inc. (“Merger Sub,” and together with Parent, “Fresenius”). Pursuant to the terms of the Merger...

May 23, 2017 04:05 pm ET

Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Akorn, Inc. - AKRX

NEW YORK, May 23, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Akorn, Inc. ("Akorn" or the "Company") (NASDAQGS: AKRX) relating to the sale of the Company to affiliates of Fresenius Kabi. As a result of the merger, Akorn shareholders are only anticipated to receive $34.00 per share in cash in exchange for each share of Akorn.

Apr 28, 2017 08:17 pm ET

Lifshitz & Miller LLP Announces Investigation of AdvancePierre Foods Holdings, Inc., Akorn, Inc., AllianceMMA, Inc., Altisource Portfolio Solutions, DelTaco Restaurants, Inc., Express Scripts Holding

NEW YORK, April 28, 2017 /PRNewswire/ --

Apr 25, 2017 07:40 pm ET

AKORN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akorn, Inc.

NEW ORLEANS, April 25, 2017 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) to Fresenius Kabi. Under the terms of the proposed transaction, shareholders of Akorn will receive only $34.00 in cash for each share of Akorn that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

You are here

(:AKRX)

Business Focus: N/A